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(FAs) are utilized for hepatic triacylglycerol (TG) generation upon tion and liver stress linked to improved systemic insulin
fasting. However, their potential impact as signaling molecules is
not established. Herein we examined the role of exogenous
AT-derived FAs in the regulation of hepatic gene expression by
investigating mice with a defect in AT-derived FA supply to the
liver.
Methods: Plasma FA levels, tissue TG hydrolytic activities and
lipid content were determined in mice lacking the lipase
co-activator comparative gene identiﬁcation-58 (CGI-58) selec-
tively in AT (CGI-58-ATko) applying standard protocols. Hepatic
expression of lipases, FA oxidative genes, transcription factors,
ER stress markers, hormones and cytokines were determined by
qRT-PCR, Western blotting and ELISA.
Results: Impaired AT-derived FA supply upon fasting of
CGI-58-ATko mice causes a marked defect in liver
PPARa-signaling and nuclear CREBH translocation. This severely
reduced the expression of respective target genes such as the
ATGL inhibitor G0/G1 switch gene-2 (G0S2) and the endocrine
metabolic regulator FGF21. These changes could be reversed by
lipid administration and raising plasma FA levels. Impaired
AT-lipolysis failed to induce hepatic G0S2 expression in fasted
CGI-58-ATko mice leading to enhanced ATGL-mediated
TG-breakdown strongly reducing hepatic TG deposition. On highJournal of Hepatology 20
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Conclusions: AT-derived FAs are a critical regulator of hepatic
fasting gene expression required for the induction of
G0S2-expression in the liver to control hepatic TG-breakdown.
Interfering with AT-lipolysis or hepatic G0S2 expression repre-
sents an effective strategy for the treatment of hepatic steatosis.
 2015 European Association for the Study of the Liver. Published
by Elsevier B.V. Open access under CC BY license.Introduction
In mammals, the deposition and mobilization of triacylglycerol
(TG) from adipose tissue (AT) plays a central role in energy home-
ostasis. This steadily recurring metabolic circuit is sensed by the
liver and reﬂected by continuous changes in hepatic TG content
and gene expression. Imbalances in this process may lead to pro-
nounced fat accumulation in the liver eventually progressing to
non-alcoholic fatty liver disease (NAFLD).
The catabolism of endogenous TG deposited within cellular
lipid droplets (LDs) depends on adipose triglyceride lipase
(ATGL) [1] and a co-activator designated as comparative gene
identiﬁcation-58 (CGI-58) [2]. Both, mutated ATGL or CGI-58 alle-
les promote neutral lipid storage disease (NLSD) characterized by
TG accumulation in multiple tissues [3] including the liver. In
mice, downregulation or absence of ATGL or CGI-58 in the liver
provokes marked hepatic fat accumulation [4–6]. Upon fasting,
hepatic TG levels sharply increase due to enhanced TG mobiliza-
tion from AT and increased fatty acid (FA) ﬂow to the liver. Excess
hepatic TG in NAFLD patients substantially originates from
AT-derived FAs [7]. However, the functional importance of
AT-derived FAs in the regulation of hepatic gene expression is
still unclear and challenged by the study of Chakravarthy et al.
[8] suggesting that PPARa-regulated gene expression in the liver
depends on de novo FA synthesis. The aim of this study was to
unravel the in vivo role of exogenously supplied FAs in the regu-
lation of hepatic gene expression and TG homeostasis upon
fasting.15 vol. 63 j 437–445
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Here we show that AT-derived FA supply is critically required
to stimulate expression of genes in the liver which are under the
dual regulation of PPARa and cAMP-responsive element binding
protein H (CREBH) encompassing the lipase inhibitor G0S2 and
the endocrine metabolic regulator ﬁbroblast growth factor 21
(FGF21) which has major implications on hepatic TG catabolism
and systemic energy homeostasis.Materials and methods
Mouse models
CGI-58-ﬂoxed mice [9] and Fabp4-Cre transgenic mice [10] have previously been
described and used for the generation of mice with AT-selective disruption of
CGI-58 (CGI-58-ATko). Mice lacking ATGL speciﬁcally in AT (ATGL-ATko) were
generated by breeding the AdipoQ-Cre transgene onto an ATGL-ﬂoxed background
[11]. Maintenance of mice is described in detail in the Supplementary Material.
Analysis of body composition
Body composition of non-fasted animals was determined using a calibrated
Bruker miniSpec NMR analyzer (Bruker Optics).
Blood parameters
Determination of plasma parameters is described in the Supplementary Material.
PPARa-agonist application and raising plasma FA levels
The established PPARa agonist Wy14643 was injected (50 lg/g body weight) into
12 h fasted mice. After another 2 h fasting the liver was surgically removed for
RNA isolation and qRT-PCR. For raising circulating FA levels, an intragastric olive
oil gavage (200 ll/mouse) was administered to 12 h fasted mice followed by hep-
arin injection (10 IU/mouse). After another 2 h, blood was collected and liver tis-
sues were harvested.
Analysis of gene expression by qRT-PCR
qRT-PCR and Xbp1-splicing assay was performed as described in the
Supplementary Material.
Measurement of tissue TG levels
Tissue lipids were extracted with chloroform and methanol and determined as
described in the Supplementary Material.
Western blotting
Western blot analyses were performed according to standard protocols described
in the Supplementary Material.
Electron microscopy
Electron microscopy has been performed as previously described [12].
Statistical analysis
Statistical signiﬁcance was determined by the Student’s unpaired t test
(two-tailed). Group differences considered signiﬁcant for p <0.05 (⁄), p <0.01
(⁄⁄), and p <0.001 (⁄⁄⁄).438 Journal of Hepatology 201Results
AT-derived FAs are critically required to induce G0S2 expression in
the liver to regulate hepatic TG catabolism upon fasting
Efﬁcient cellular TG catabolism depends on ATGL and the lipoly-
tic co-activator CGI-58 [1]. To restrict FA release from AT, we gen-
erated mice lacking CGI-58 selectively in AT (CGI-58-ATko) by
breeding Fabp4-Cre transgenic mice [10] with mice carrying
loxP-sites in the Cgi-58 gene [9]. CGI-58 expression was substan-
tially reduced in gonadal white and brown AT of CGI-58-ATko
mice (Fig. 1A; Supplementary Fig. 1A) whereas muscle and hep-
atic CGI-58 mRNA levels were comparable to ﬂox/ﬂox controls.
Body weight of CGI-58-ATko mice was similar to ﬂox/ﬂox controls
(Supplementary Fig. 1B) whereas body fat mass was 1.4-fold
increased paralleled by elevated gonadal and brown AT and
reduced liver mass (Supplementary Fig. 1C and D). Fasting pro-
voked a marked decrease in plasma FA (66%), TG (58%) and
glycerol levels in CGI-58-ATko mice (Table 1). Plasma levels of
long-chain saturated and unsaturated FA species were signiﬁ-
cantly decreased (ranging from 29% up to 73%) (Fig. 1B). The
reduction in blood glucose and plasma insulin levels together
with lower HOMA-IR indexes in CGI-58-ATko compared to
ﬂox/ﬂox mice (Table 1) indicates increased insulin sensitivity.
Hepatic glycogen content was markedly reduced (74%) in 6 h
fasted CGI-58-ATko compared to ﬂox/ﬂox mice (3.6 ± 5.6 vs.
13.5 ± 6.1 mg glucose per g tissue, respectively). Together, these
data validate CGI-58-ATko mice to study the impact of defective
AT-lipolysis on hepatic TG homeostasis and gene expression.
Hepatic TG (Fig. 1C) and total cholesterol (Supplementary
Fig. 1E) levels were unchanged in non-fasted CGI-58-ATko com-
pared to ﬂox/ﬂox mice whereas TG levels were strongly reduced
(71%) in fasted CGI-58-ATko mice compared to controls.
Examination of liver tissue morphology by transmission electron
microscopy (Fig. 1D) revealed very low abundance of LDs in liver
sections of fasted CGI-58-ATko mice and counting of LDs showed
a 9.2-fold reduction in LD numbers of nearly all sizes
(Supplementary Fig. 1F). Notably, TG hydrolytic activities
(Fig. 1E) were exclusively and markedly increased in liver prepa-
rations of fasted CGI-58-ATko compared to control mice, and
addition of a speciﬁc ATGL inhibitor [13] to tissue preparations
reduced activities to ﬂox/ﬂox levels suggesting increased
ATGL-mediated TG-breakdown. In accordance with this assump-
tion, hepatic ATGL expression was markedly increased in fasted
CGI-58-ATko mice (up to 1.7-fold) whereas expression of the
ATGL inhibitor G0S2 [14] was drastically reduced on the mRNA
(3.7-fold) and protein level (5.5-fold) (Fig. 1F and G). The
strong reduction of hepatic G0S2 expression suggests that the
increase in hepatic TG breakdown is mainly due to failed induc-
tion of hepatic G0S2 expression in the liver. To corroborate this
conclusion and to conﬁrm that CGI-58 disruption affected hepatic
gene expression via defective AT-lipolysis, we measured G0S2
protein levels in ATGL-ATko mice which signiﬁcantly impairs
AT-lipolysis in the fasted state [15,16]. ATGL was disrupted in
AT by breeding Atgl-ﬂoxed mice [11] with AdipoQ-Cre transgenic
mice. In line with CGI-58-ATko mice, hepatic G0S2 expression
was strongly reduced whereas ATGL expression was increased
in fasted ATGL-ATko mice (Supplementary Fig. 1G).5 vol. 63 j 437–445
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Fig. 1. AT-derived FAs induce G0S2 expression in the liver to regulate hepatic TG catabolism. (A) Absence of CGI-58 protein expression in white (gonadal) and brown AT
(WAT and BAT) of CGI-58-ATko mice. (B) Plasma concentrations of saturated and unsaturated FA species in fasted ﬂox/ﬂox and CGI-58-ATko mice. (C) Hepatic TG levels in
non-fasted compared to fasted ﬂox/ﬂox and CGI-58-ATko mice. (D) Transmission electron microscopy of liver sections from fasted mice (Scale bar = 1 lm; LD, lipid droplet;
m, mitochondria; n, nucleus). (E) TG hydrolytic activities in liver preparations of non-fasted compared to fasted mice and in the presence of an ATGL-speciﬁc inhibitor
(ATGLi). (F) Hepatic ATGL and G0S2 mRNA expression in non-fasted compared to fasted mice. (G) Hepatic ATGL and G0S2 protein expression upon fasting. Values are
mean ± SD from at least 5 mice per genotype. *p <0.05, **p <0.01, and ***p <0.001 vs. ﬂox/ﬂox; #p <0.05 and ###p <0.001 non-fasted vs. fasted.
Table 1. Plasma energy metabolites in non-fasted compared to fasted ﬂox/ﬂox
and CGI-58-ATko mice on chow. Plasma glucose, insulin and HOMA-IR refer to
6 h fasted mice.
flox/flox CGI-58-ATko flox/flox CGI-58-ATko
Non-fasted Overnight fasted
FAs (mmol/L) 0.60 ± 0.25 0.54 ± 0.20 1.04 ± 0.28 0.35 ± 0.15***
TG (mg/dl) 89 ± 20 74 ± 19 67 ± 30 28 ± 11*
Glycerol (nmol/µl) 0.43 ± 0.24 0.41 ± 0.23 0.53 ± 0.22 0.19 ± 0.10***
Glucose (mg/dl) 145 ± 34 142 ± 28 139 ± 13 113 ± 24*
Insulin (ng/ml) 0.38 ± 0.21 0.29 ± 0.19 0.47 ± 0.24 0.11 ± 0.07**
HOMA-IR n.d. n.d. 3.5 ± 1.2 0.9 ± 0.5**
Values represent mean ± SD; *p <0.05, **p <0.01, ***p <0.001 (nP6).
JOURNAL OF HEPATOLOGYFasting-induced expression of PPARa-regulated genes in the liver
including FGF21 depends on peripheral FA supply
The defect in AT-lipolysis profoundly interfered with hepatic TG
catabolism via lack of fasting-induced G0S2 expression in the
liver of CGI-58-ATko mice. Hepatic G0S2 mRNA expression is
under the regulation of PPARa [17] indicating that AT-derived
FAs impact PPARa-regulated gene expression in the liver. As
shown in Fig. 2A, hepatic mRNA levels of PPARa and genes regu-
lated or co-regulated by PPARa including FGF21, acyl-CoA oxidase
(AOX1), medium-chain acyl-CoA dehydrogenase (MCAD) and
long-chain acyl-CoA dehydrogenase (LCAD) were signiﬁcantly
decreased in the liver of overnight-fasted CGI-58-ATko mice
(ranging from 35% to 86%) compared to levels of ﬂox/ﬂox
mice. In contrast, mRNA expression of PPARa-regulated genes
was similar in non-fasted CGI-58-ATko compared to control mice.
In line with low mRNA expression, plasma FGF21 concentration
was reduced by 48% (Fig. 2B). Next we examined expression of
the transcriptional co-activator PGC-1a and hepatocyte nuclear
factor 4alpha (HNF4a) which are highly expressed in the liver
and bind to FAs [18]. Interestingly, and in contrast to reducedJournal of Hepatology 201PPARa target gene expression, hepatic PGC-1a and HNF4a expres-
sion increased in fasted CGI-58-ATko compared to ﬂox/ﬂox mice
on the mRNA (Fig. 2C) and nuclear protein level
(Supplementary Fig. 2A and B). Unlike impaired PPARa-target
gene expression in the liver, defective AT-lipolysis in
CGI-58-ATko mice does not interfere with PPARa-regulated gene
expression including FGF21 in cardiac and skeletal muscle
(Supplementary Fig. 2C and D), which is in accordance with
results of previous studies showing that PPARa-activation in car-
diac muscle is not affected by low levels of exogenous FAs [9,12].
As ‘‘proof of principle’’ we examined PPARa-regulated gene
expression in the liver of fasted ATGL-ATko mice which also exhi-
bit a marked defect in AT-lipolysis. AT-speciﬁc ATGL disruption
showed an essentially identical hepatic mRNA expression proﬁle
except that PGC-1a mRNA expression was even more strongly
increased (8.1-fold) compared to ﬂox/ﬂox controls
(Supplementary Fig. 2E and F) further corroborating the critical
role of AT-lipolysis in the regulation of hepatic fasting gene
expression. To examine whether these changes in hepatic gene
expression are directly mediated by low exogenous FA levels
we followed a strategy where we increased circulating FA levels
in fasted mice via intragastric olive oil administration followed
by heparin injection to release lipoprotein lipase (LPL) thereby
increasing TG-breakdown and circulating FA levels. Notably, 2 h
after the lipid administration, hepatic mRNA expression of
selected PPARa-regulated genes including FGF21 signiﬁcantly
increased in CGI-58-ATko mice (Fig. 2D) and the effect was most
pronounced for G0S2. These changes were paralleled by increased
FA levels in CGI-58-ATko (and ﬂox/ﬂox) mice implicating that the
increase in PPARa target mRNA expression was linked to the raise
in circulating FA levels.
Reduced circulating FGF21 levels and the increase in hepatic
PGC-1a and HNF4a expression in CGI-58-ATko mice prompted
us to further examine the consequences on energy metabolism.
FGF21 induces ketogenic gene expression in the liver and plays5 vol. 63 j 437–445 439
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Fig. 2. Hepatic FGF21 and PPARa-regulated gene expression depends on exogenous FA supply. (A) Hepatic mRNA expression of PPARa-regulated genes in non-fasted
compared to fasted mice determined by qRT-PCR. (B) Plasma FGF21 concentrations in fasted ﬂox/ﬂox and CGI-58-ATko mice. (C) Hepatic PPARa and HNF4a mRNA
expression determined by qRT-PCR. (D) mRNA levels of PPARa-regulated genes in the liver of fasted mice following intragastric olive oil administration and heparin
injection which raises plasma FA levels (right panel). (E) Fasting plasma levels of b-hydroxybutyrate (b-HB) and (F) hepatic HMGCS2 mRNA expression. Values are
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CGI-58-ATko fasted vs. lipid and heparin administration in CGI-58-ATko mice.
Research Articlea critical role in regulating body temperature [19]. Impaired hep-
atic FGF21 expression in CGI-58-ATko mice was paralleled by sig-
niﬁcantly reduced (66%) plasma ketone body concentrations
(b-hydroxybutyrate) (Fig. 2E) and reduced (69%) mRNA expres-
sion of HMG-CoA synthase-2 (Fig. 2F), the rate-limiting enzyme in
ketogenesis. Next we tested the impact of fasting on cold adapta-
tion of CGI-58-ATko mice (Supplementary Fig. 3A and B). In con-
trast to the non-fasted state, fasting provoked a rapid decline in
body temperature of CGI-58-ATko mice which disposed us to ter-
minate the experiment. Hepatic gluconeogenesis is under the
dual regulation of PGC-1a and HNF4a [20]. mRNA expression of
PEPCK and G6P (Supplementary Fig. 3C) was increased in
CGI-58-ATko compared to ﬂox/ﬂox controls (1.6- and 1.5-fold,
respectively). However, pyruvate tolerance test revealed a mod-
erate decrease in hepatic glucose production of CGI-58-ATko mice
(Supplementary Fig. 3D) indicating no gross alterations in the
gluconeogenic pathway.
Exogenous FA supply stimulates nuclear CREBH translocation and
interferes with the ER stress pathway
The changes in hepatic gene expression of CGI-58-ATko mice
prompted us to further explore the underlying mechanisms.
Considering the established role of FAs as PPARa ligands it is con-
ceivable that defective AT-lipolysis restricts ligand availability in
the liver. Application of the established PPARa ligand Wy14643
further increased hepatic mRNA levels of PPARa-regulated genes
(Fig. 3A) in ﬂox/ﬂox control mice (including a 2.9- and 4.5-fold
increase in FGF21 and G0S2 expression) whereas mRNA expres-
sion of these genes remained low in CGI-58-ATko mice. Failed
recovery of hepatic gene expression in CGI-58-ATko mice440 Journal of Hepatology 201suggested an additional ligand-independent defect. Global
CREBH-deﬁciency was shown to markedly impair FGF21 and
G0S2 mRNA expression in the liver [21,22] suggesting that these
genes are under dual regulation of PPARa and CREBH. Fasting
similarly increases CREBH mRNA expression in the liver of
ﬂox/ﬂox and CGI-58-ATko mice (Fig. 3B). CREBH-activated gene
expression requires translocation of processed microsomal
CREBH to the nucleus. Notably, CREBH protein was substantially
reduced (91%) in nuclear preparations derived from liver tissue
of fasted CGI-58-ATko compared to ﬂox/ﬂox mice (Fig. 3C) sug-
gesting a defect in CREBH-activated gene expression.
CREBH cleavage and nuclear translocation is known to be
induced by fasting [21] and endoplasmic reticulum (ER) stress
[23]. It is conceivable that the fasting-induced enhanced ﬂow of
exogenous FAs to the liver can be sensed by hepatocyte ER
thereby affecting expression of genes linked to the ER stress path-
way. Fasting substantially increased mRNA expression of molec-
ular chaperones and ER stress markers (Supplementary Fig. 4A)
encompassing glucose-regulated protein 78 (Grp78/BiP), C/EBP
homologous protein (Chop), protein disulﬁde isomerase (Pdi)
and ER DnaJ homologue 4 (Erdj4) in the liver of ﬂox/ﬂox mice
(ranging from 1.6- up to 3.3-fold). This induction was absent or
less pronounced in the liver of fasted CGI-58-ATko mice. On the
protein level, Pdi signal intensity was signiﬁcantly reduced
(62%) in CGI-58-ATko liver preparations (Fig. 3D) whereas
Grp78/BiP protein expression was comparable to ﬂox/ﬂox con-
trols (not shown). To further examine whether fasting interferes
with hepatic ER stress we measured protein and/or phosphory-
lated protein levels of the three ER transmembrane effector pro-
teins of the unfolded protein response (UPR) and their
downstream targets including the activating transcription5 vol. 63 j 437–445
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##p <0.01, and ###p <0.001 non-fasted vs. fasted or vehicle vs. Wy14643.
JOURNAL OF HEPATOLOGYfactor-6 (ATF-6), inositol requiring enzyme 1 (IRE1) and PKR-like
ER kinase (PERK). ATF-6 protein expression was 1.8-fold
increased in liver preparations of fasted CGI-58-ATko compared
to ﬂox/ﬂox mice whereas IRE1a levels were comparable to
ﬂox/ﬂox samples (Fig. 3E). Hepatic JNK protein levels and ratio
of phosphorylated to total JNK were unchanged in CGI-58-ATko
mice compared to ﬂox/ﬂox controls which is in accordance with
unchanged mRNA levels of the PPARa co-repressors Ncor1 and
Nrip1 (Supplementary Fig. 4B) which are under regulation of
JNK [24]. Additionally, ratio of phosphorylated to total PERK
was moderately increased in liver preparations of CGI-58-ATko
mice whereas the ratio of phosphorylated to total eIF2alpha
was unchanged (Fig. 3F). Finally, the increase in ATGL expression
prompted us to measure protein levels of the forkhead box O1
(FoxO1) transcription factor which has been shown to increase
ATGL expression in AT [25]. Insulin stimulates
FoxO1-phosphorylation thereby preventing nuclear transloca-
tion. Cytosolic FoxO1 protein levels were reduced whereas
nuclear levels increased (Supplementary Fig. 4C) indicating that
FoxO1 may play a role in the induction of hepatic ATGL expres-
sion in fasted CGI-58-ATko mice. Plasma levels of alanine amino-
transferase (ALT), as an indicator for liver injury, were similar in
CGI-58-ATko compared to ﬂox/ﬂox mice (23.2 ± 6.3 vs. 25.7 ± 9.1).Journal of Hepatology 201Impaired AT-lipolysis counteracts hepatic steatosis, reduces hepatic
stress and improves systemic insulin sensitivity of CGI-58-ATko mice
on high fat diet
Feeding a high fat diet (HFD) comparably increased body weight
and fat mass of ﬂox/ﬂox and CGI-58-ATko mice whereas lean
mass was moderately reduced in CGI-58-ATko mice
(Supplementary Fig. 5A and B). Gonadal AT depots were
unchanged whereas brown AT mass was increased and liver mass
was reduced in CGI-58-ATko compared to ﬂox/ﬂox mice (Fig. 4A).
Plasma FA, glucose and insulin levels and HOMA-IR index were
lower in CGI-58-ATko compared to ﬂox/ﬂox mice (Table 2).
Hepatic TG levels were reduced (37%) in CGI-58-ATko mice
whereas total cholesterol levels were comparable to ﬂox/ﬂox
controls (Fig. 4B). Histomorphological analyses showed the pres-
ence of partially large LDs in hepatocytes of both genotypes,
whereas LD numbers were 1.6-fold reduced in CGI-58-ATko hep-
atocytes (Fig. 4C; Supplementary Fig. 5C). Hepatic TG hydrolytic
activities and ATGL expression were moderately increased in
CGI-58-ATko compared to ﬂox/ﬂox mice (Fig. 4D;
Supplementary Fig. 5D and E) whereas mRNA levels of
PPARa-regulated genes (Fig. 4E) and plasma FGF21 concentra-
tions (Table 2) remained low in CGI-58-ATko mice on HFD.5 vol. 63 j 437–445 441
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Similarly, G0S2 protein expression (Fig. 4F) and nuclear abun-
dance of CREBH (Fig. 4G) were reduced in CGI-58-ATko mice com-
pared to controls albeit CREBH levels strongly increased in both
genotypes on HFD. Next we investigated the impact of HFD on
hepatic stress parameters. Notably, reduced plasma ALT levels
(Table 2) together with a signiﬁcant decrease (65%) in the ratio
of phosphorylated to total JNK (Fig. 4H) indicates that impaired
AT-lipolysis counteracts the development of hepatic injury and
stress. Furthermore, reduced levels of spliced Xbp-1 mRNA
(Fig. 4I) indicate less induction of the UPR. However, levels of
other proteins from the UPR (Supplementary Fig. 5F–H) were
similar in both genotypes except for a moderate reduction in
the ratio of phosphorylated vs. total PERK and decreased Pdi
expression in CGI-58-ATko mice. Finally, we investigated the
impact of HFD on hepatic insulin signaling. Hepatic ratio of phos-
phorylated (pSer473) vs. total Akt was mildly increased in
CGI-58-ATko mice on chow whereas the ratio was similar in both
genotypes on HFD (Supplementary Fig. 5I).200 bp
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Fasting is associated with increased activity of transcription fac-
tors in the liver which are directly or indirectly activated by FAs
[18], including PPARs, CREBH and HNF4a. Yet, the role of
AT-derived FAs in the regulation of hepatic gene expression is
still unclear. In this study we investigated the functional role of
AT-derived FAs in the regulation of hepatic gene expression.
We found that defective AT-lipolysis in mice, lacking the lipolytic
co-activator CGI-58 (or ATGL) in AT, severely impairs PPARa and
CREBH co-regulated gene expression in the liver.
Our study demonstrates that hepatic expression of the lipase
inhibitor G0S2 and the metabolic regulator FGF21 essentially
depend on FA supply from AT. Recently, G0S2 has emerged as
an important metabolic regulator [26,27] via acting as a lipolytic
suppressor. G0S2 is inversely expressed in AT and liver depend-
ing on the nutritional state: Fasting lowers G0S2 expression in
AT to enhance lipolysis and FA supply. In contrast, G0S20 
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Table 2. Plasma energy metabolites and hormone levels in fasted ﬂox/ﬂox
compared to CGI-58-ATko mice on HFD. Plasma insulin and HOMA-IR refer to
6 h fasted mice.
flox/flox CGI-58-ATko
FAs (mmol/L) 1.32 ± 0.28 0.91 ± 0.11*
Glucose (mg/dl) 147 ± 41 110 ± 20p = 0.08
Insulin (ng/ml) 0.71 ± 0.39 0.34 ± 0.15*
HOMA-IR 4.2 ± 0.8 1.1 ± 1.0*
FGF21 (pg/ml) 1750 ± 221 875 ± 293***
ALT (U/L) 33.3 ± 8.2 18.4 ± 4.6*
Values represent mean ± SD; *p <0.05, **p <0.01, ***p <0.001 (nP5).
JOURNAL OF HEPATOLOGYexpression increases in the liver upon fasting to suppress TG cat-
abolism thereby preserving hepatic TG as an energy source or
pool for lipoprotein biogenesis or signaling molecules. However,
the mechanism and metabolites or hormones regulating G0S2
expression in the liver remain unclear. Our study provides several
lines of evidence that G0S2 expression is regulated via exogenous
FA ﬂow to the liver: i) Defective AT-lipolysis was associated with
the absence of fasting-induced G0S2 mRNA expression in the
liver which was reversed by raising fasting plasma FA levels;
and ii) Defective AT-lipolysis was linked to low nuclear levels
of processed active CREBH. This is in line with the severe reduc-
tion in hepatic G0S2 expression of mice globally lacking CREBH
[21,22].
Low hepatic G0S2 expression was paralleled by increased TG
hydrolytic activities in liver preparations of CGI-58-ATko mice
which was reduced to control levels by incubation with a speciﬁc
ATGL inhibitor [13] suggesting that the decline in hepatic TG is
mainly due to increased ATGL-mediated TG catabolism. In line
with this conclusion, liver-speciﬁc G0S2 overexpression leads to
hepatic steatosis [26,28]. Liver-speciﬁc G0S2 knockdown does
not affect fasting plasma FA levels and leads to increased ketoge-
nesis and FAO gene expression by increasing hepatic TG catabo-
lism [26]. Interestingly, and in strong contrast, impaired hepatic
G0S2 expression in CGI-58-ATko mice reduced ketone body
levels, FAO and ketogenic gene expression indicative for a critical
role of AT-derived FAs in the regulation of the hepatic fasting
response. Additionally, hepatic glycogen levels increased upon
liver-speciﬁc G0S2 knockdown whereas glycogen was depleted
in fasted CGI-58-ATko mice which may be the consequence of
restricted availability of FAs as energy fuel in CGI-58-ATko mice.
Interestingly, it has been reported that the interaction of the
nuclear transcription factors PGC-1a and FOXO1 stimulates glu-
coneogenesis [29] and that PGC-1a induces gluconeogenesis in
an HNF4a-dependent manner [20]. Considering the increased
nuclear abundance of the aforementioned transcription factors
in fasted CGI-58-ATko mice of this study, one would predict
increased gluconeogenesis. However, we found that hepatic glu-
cose production was moderately reduced in CGI-58-ATko mice in
contrast to mice with hepatic G0S2 knock down, which increases
hepatic glucose production in pyruvate tolerance tests. Hepatic
glucose formation in the fasted state also involves the utilization
of AT-derived glycerol as metabolite and glycogenolysis. It is con-
ceivable that lowered glucose production in response to pyruvate
administration in fasted CGI-58-ATko mice involves the depriva-
tion of glycerol and glycogen and possibly restricted FA supply as
energy fuel.
Notably, the induction of hepatic TG-breakdown either in
mice globally lacking G0S2 or in mice lacking CGI-58 in AT thatJournal of Hepatology 201were fed a HFD increased systemic insulin sensitivity.
Furthermore, both mutant mouse models exhibited similarly
reduced plasma ALT levels demonstrating that the stimulation
of hepatic TG-breakdown per se counteracts the development of
metabolic disorders. Similar to impaired G0S2 expression, we
show that the induction of hepatic FGF21 expression depends
on AT-FA supply. FGF21 expression not only stimulates ketogen-
esis but also regulates cold adaptation and systemic energy meta-
bolism. The severe defect in cold adaptation observed in fasted
CGI-58-ATko mice further demonstrates the critical role of
AT-derived FAs in the induction of hepatic FGF21 expression
and the regulation of whole body energy homeostasis [19].
Interestingly, hepatic FGF21 expression and serum FGF21 levels
have been reported to be signiﬁcantly increased in obese patients
[30] and may involve changes in exogenous FA levels.
In this study we found that PPPAa-ligand treatment of
CGI-58-ATko mice did not recover PPARa-regulated gene expres-
sion in the liver suggesting a PPARa ligand-independent defect.
Recently Kim et al. [31] showed that a mutual transcriptional reg-
ulation exists between CREBH and PPARa and that PPARa
requires CREBH for trans-activation of FGF21 gene expression.
The extremely low protein levels of processed nuclear CREBH in
fasted CGI-58-ATko mice suggested that AT-derived FAs are an
important energy sensor for the liver, required for CREBH cleav-
age and nuclear translocation to activate G0S2 and FGF21 gene
expression. CREBH was originally discovered as an ER stress reg-
ulated gene, albeit its role in ER stress is a matter of discussion
[32]. Impaired AT-lipolysis divergently interfered with protein
expression and/or activation of the three major regulators of
the UPR pathways, including increased ATF6 protein expression
and PERK-phosphorylation in CGI-58-ATko mice on chow, impli-
cating that low nuclear abundance of CREBH was not due to clas-
sic induction of hepatic ER stress and involves a currently
unknown mechanism.
It is conceivable that the increase in LD-formation in the
fasted state (which is impaired in CGI-58-ATko mice) is sensed
by the ER and triggers CREBH cleavage and nuclear translocation
which is required for PPARa- and CREBH-coordinated expression
of G0S2 and FGF21 (Fig. 4J) to regulate hepatic and whole body
TG homeostasis. The fasting-stimulated induction of G0S2
expression may protect the liver from excessive TG catabolism
which preserves TG as energy fuel and reservoir for
lipoprotein-TG synthesis under normal diet. Under conditions
of increased plasma FA levels, as exempliﬁed in mice fed a HFD,
a sustained G0S2-mediated suppression of hepatic TG catabolism
may lead to the development of hepatic steatosis and the activa-
tion of the UPR. In line with such an assumption, reduced plasma
FA levels of CGI-58-ATko mice on HFD were accompanied by
increased hepatic TG-breakdown, reduced levels of phosphory-
lated JNK and PERK together with decreased mRNA levels of
spliced Xbp-1 in liver tissue of CGI-58-ATko mice. Additionally,
reduced insulin levels and HOMA-IR in CGI-58-ATko mice on
HFD suggest that the reduction in circulating FA levels due to
impaired AT-lipolysis counteracts the development of whole
body and possibly hepatic insulin resistance.
Together, in this study we show that induction of G0S2 and
FGF21 expression in the liver depends on FA supply from AT
and that plasma FA levels correlate with hepatic G0S2 expression
and nuclear abundance of CREBH. Accordingly, a surplus of
plasma FAs, linked to obesity and/or dietary fat content, may pro-
mote hepatic fat accumulation via sustained suppression of5 vol. 63 j 437–445 443
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hepatic TG catabolism. Impaired hepatic TG catabolism leads to
hepatic steatosis in humans and mice [5,6,33]. Inhibition of
AT-lipolysis or hepatic G0S2 expression may represent an effec-
tive strategy to enhance hepatic TG catabolism thereby counter-
acting hepatic fat accumulation and NAFLD development.Financial support
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